#SmallCapSummer
#SmallCapSummer

#SmallCapSummer

Stocks under $10 - sorted by price group and industry. Toggle the views, sort and group features or filter to explore the table. 

Download the All of Us Financial app to start investing and trading.

All of Us Financial
All of Us Financial
18th July 2021 in finance
View:
Suggest Item
Use this list
Company
Company
Approx. Price
Symbol
Description
Industry
Price Group

Price Group
~ $0.50

19

CHINA XD PLASTICS COMPANY LIMITED (XNAS:CXDC)

$0.54
CXDC
China XD Plastics Company Limited (China XD) is a specialty chemical company. The Company is engaged in the research, development, manufacture and sale of modified plastics for automotive applications in China and to a lesser extent, in Dubai, the United Arab Emirates (UAE). The Company operates in the modified plastics segment. Through its subsidiaries, Heilongjiang Xinda Enterprise Group Company Limited (HLJ Xinda Group) and AL Composites Materials FZE (Dubai Composites), the Company manufactures and sells polymer composite materials (including modified plastics), for automotive applications. The Company's products categories include Modified Polypropylene (PP), Modified Acrylonitrile Butadiene Styrene (ABS), Modified Polyamide 66 (PA66), Modified Polyamide 6 (PA6), Modified Polyoxymethylenes (POM), Modified Polyphenylene Oxide (PPO), Plastic Alloy, Modified Polyphenylene Sulfide (PPS), Modified Polyimide (PI), Modified Polylactic Acid (PLA) and Poly Ether Ether Ketone (PEEK).
  • Automobiles & Auto Parts
~ $0.50
26

CDTI ADVANCED MATERIALS, INC. (OTCM:CDTI)

$0.65
CDTI
CDTi Advanced Materials, Inc., formerly Clean Diesel Technologies, Inc., commercializes its material technology by manufacturing and distributing light duty vehicle catalysts, and heavy duty diesel emissions control systems and products to automakers, distributors, integrators and retrofitters. The Company operates through two business division segments: Catalyst, which develops catalysts to reduce emissions from gasoline, diesel and natural gas combustion engines, and Heavy Duty Diesel Systems, which manufactures verified exhaust emissions control solutions for a range of heavy duty diesel applications. It develops materials incorporating various base metals that replace platinum group metals (PGM) and rare earth metals in coatings on vehicle catalytic converters. Its technologies include Spinel, base-metal activated rhodium on Support, mixed phase catalyst, synergized PGM diesel oxidation catalyst, Platinum Plus, ARIS, and Exhaust Gas Recirculation and Selective Catalytic Reduction.
  • Automobiles & Auto Parts
~ $0.50
6

ANTHERA PHARMACEUTICALS, INC. (OTCM:ANTH)

$0.07
ANTH
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.
  • Biotechnology & Medical Research
~ $0.50
10

BIOSTAR PHARMACEUTICALS, INC (OTCM:BSPM)

$0.15
BSPM
Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The Company offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The Company's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The Company's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.
  • Biotechnology & Medical Research
~ $0.50
17

ADVAXIS, INC. (XNAS:ADXS)

$0.49
ADXS
Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.
  • Biotechnology & Medical Research
~ $0.50
20

Acasti Pharma Inc. (XNAS:ACST)

$0.56
ACST
Acasti Pharma Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. It is developing a cardiovascular drug, CaPre (omega-3 phospholipid) for the treatment of hypertriglyceridemia. CaPre is a krill oil derived mixture containing polyunsaturated fatty acids (PUFAs), primarily composed of omega-3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). CaPre is designed to reduce triglycerides while also potentially providing beneficial effects on low-density lipoprotein (LDL) cholesterol (LDL-C) and high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with severe hypertriglyceridemia.
  • Biotechnology & Medical Research
~ $0.50
21

ACURA PHARMACEUTICALS, INC. (OTCM:ACUR)

$0.58
ACUR
Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The Company's Oxaydo Tablets (oxycodone HCl, CII), which utilizes the Aversion Technology, is an approved and immediate-release (IR) oxycodone product in the United States. The Company's Impede technology products include Nexafed and Nexafed Sinus Pressure + Pain. Its third deterrent technology is Limitx, which is designed to retard the release of active drug ingredients when too many tablets are accidently or purposefully ingested. The Company's Aversion and Limitx technologies are intended to address methods associated with opioid and its Impede technology is directed at the extraction and conversion of pseudoephedrine into methamphetamine.
  • Biotechnology & Medical Research
~ $0.50
24

ENZON PHARMACEUTICALS, INC. (OTCM:ENZN)

$0.63
ENZN
Enzon Pharmaceuticals, Inc. receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products: PegIntron, Sylatron, Macugen and CIMZIA. The Company has no clinical operations and limited corporate operations. PegIntron is used both as a monotherapy and in combination with REBETOL (ribavirin) capsules for the treatment of chronic hepatitis C. Macugen is used for the treatment of neovascular (wet) age-related macular degeneration. Sylatron is used for the treatment of melanoma. CIMZIA is used for the treatment of moderate to severe rheumatoid arthritis and Crohn's disease. CIMZIA is a biologic medicine that counteracts tumor necrosis factor (or TNF), which promotes inflammation of the joints in rheumatoid arthritis.
  • Biotechnology & Medical Research
~ $0.50
23

CONSOLIDATED CONSTRUCTION CONSORTIUM LIMITED (XNSE:CCCL)

$0.60
CCCL
Consolidated Construction Consortium Limited offers construction services. The Company is engaged in construction design, engineering, procurement, construction and project management. The Company also provides construction allied services, such as mechanical and electrical, plumbing, firefighting, heating, ventilation and air conditioning, interior fit out services and glazing solutions. The Company also caters to the requirements of ready mix concrete, solid blocks and pre-cast items for clients. The Company's services include Construction, Engineering, Specialization, Project Management, Mechanical and Electrical Division, Consolidated Interiors Fit Out, Glazing Solutions, Building Products Division, Software Designs Department and Information Technology Department. The Company's projects include airports, biotech parks, commercial, convention center, factory/industry, green buildings, hospital, infrastructure, metro rails, projects abroad, residential, and resorts and hotels.
  • Construction & Engineering
~ $0.50
12

ESCALON MEDICAL CORP. (OTCM:ESMC)

$0.26
ESMC
Escalon Medical Corp. operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high frequency/high resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company's pachymeter measures the thickness of the cornea. Its color/fluorescein angiography digital imaging system is designed for ophthalmology. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery.
  • Healthcare Equipment & Supplies
~ $0.50
25

BIOLASE, INC. (XNAS:BIOL)

$0.64
BIOL
BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
  • Healthcare Equipment & Supplies
~ $0.50
8

FINCANNA CAPITAL CORP. (XCNQ:CALI)

$0.09
CALI
Fincanna Capital Corp is a royalty company. The Company provides growth capital to emerging private companies operating in the licensed United States (U.S) cannabis industry. The Company earns its revenue from royalties paid by its investee companies that are calculated based on a percentage of their total revenues.
  • Investment Banking & Investment Services
~ $0.50
2

FBR LTD (OTCM:FBRKF)

$0.03
FBRKF
FBR Limited, formerly Fastbrick Robotics Limited, is a robotic technology company. The Company focuses on building a bricklaying machine, Hadrian X. The Company's mobile robotic technology focuses on brick and block construction industry. The Company's Hadrian X uses three-dimensional (3D) printing technology and can lay over 1,000 standard brick equivalents (SBE) per hour. Its Hadrian X uses adhesives and/or thin bed mortar and can execute the automatic loading, cutting, routing and placement of bricks to build a house. The Company's Hadrian X is truck mounted and self-powered and its 30 meter robotic arm allows completion of all brickwork from a single position. Its Hadrian X has a software, The Architectural Designer (TAD). The Company’s omni-track laser alignment system corrects dynamic interface and vibration to approximately 0.75 millimeter (mm) accuracy of computer aided design (CAD) design.
  • Machinery
  • Equipment & Components
~ $0.50
14

EGUANA TECHNOLOGIES INC. (XTSX:EGT)

$0.35
EGT
Eguana Technologies Inc. is a Canada-based company, which designs and manufactures power control solutions for grid interactive energy storage systems (ESS). The Company's integrated ESS consists of three components: the software controller/the energy management system (EMS), the battery and the advanced power controls. The Company develops and manufactures power inverters for the alternative and renewable energy industry-solar photovoltaic (PV) systems, small wind turbines, fuel cells and various forms of energy storage. The Company's power control solutions charge and discharge batteries, converting alternating current (AC) to direct current (DC) to charge and converting DC to AC to discharge batteries in a bi-directional conversion process. Its products are also the point of connectivity to the ESS and provide regulatory control over the interconnection of the ESS to the power grid and the consumer.
  • Machinery
  • Equipment & Components
~ $0.50
3

CURRIE ROSE RESOURCES INC. (XTSX:CUI)

$0.04
CUI
Currie Rose Resources Inc. is an exploration-stage company. The Company is engaged in acquisition, exploration and development of mineral resource properties. The Company's geographical segments include Canada and Tanzania. Its resource property in Canada includes Scadding and Tanzania includes Mabale Hills. The gold mining claims in Scadding Township covers an area of approximately 1,900 acres in Northern Ontario. The Company has not generated any revenues. The Company's subsidiary is Currie Rose Resources (T) Limited.
  • Metals & Mining
~ $0.50
7

Bravada Gold Corporation (XTSX:BVA)

$0.08
BVA
Bravada Gold Corporation is an exploration-stage company. The Company's principal activities include the acquisition, exploration and development of natural resource properties. Its primary focus has been the exploration for precious metals in Nevada. It holds over 10 exploration and development properties, such as Wind Mountain, Quito, Battle Mountain - Granite Mountain, Battle Mountain - Colorback, Battle Mountain - Mountain Boy (Signal and Temple), Battle Mountain - Pete Hanso, Battle Mountain - South Lone Mountain, Battle Mountain - North Lone Mountain, Battle Mountain - SF, Battle Mountain - Shoshone Pediment, Battle Mountain - Other, Highland, Baxter, East Manhattan, Millie and Drayton. It has over 1,130 claims with over 1,300 hectares of land for a total of approximately 10,000 hectares. Its Millie property consists of over 30 claims and a private land located approximately 40 kilometers southwest of Winnemucca in Pershing County.
  • Metals & Mining
~ $0.50
11

ERRAWARRA RESOURCES LTD (XASX:ERW)

$0.21
ERW
Errawarra Resources Ltd is an Australia-based company mineral exploration company, which is engaged in exploring and developing gold, nickel, copper and cobalt mineral properties. The Company holds interests in various projects, including Fraser Range Project, Binti Binti Project, and Errabiddy Project. The Fraser Range Project is mineralized in nickel, copper and cobalt, which is located approximately 130-kilometer (km) east of Norseman, Western Australia and covers an area of approximately 105km within the Dundas and Warburton Mineral Fields. The Binti Binti Project is located approximately 75km north-northeast of Kalgoorlie, Western Australia and covers an area of approximately 42km within the Kanowna Mineral Field. The Errabiddy Project is in the Gascoyne Region of Western Australia approximately 190km northwest of Meekatharra and 360km east of Carnarvon and within the Shires of Upper Gascoyne and Murchison. Its Errabiddy Project is mineralized in orogenic gold and nickel-copper.
  • Metals & Mining
~ $0.50
13

COBALT BLUE HOLDINGS LIMITED (XASX:COB)

$0.30
COB
Cobalt Blue Holdings Limited is a cobalt exploration and development company. The Company is focused on developing the Thackaringa Cobalt Project in New South Wales. The Company focuses on achieving commercial production of cobalt and commercializing technical advances in the use of cobalt. The Thackaringa Cobalt Project covers an area of approximately 60 square kilometers and is located in western New South Wales (over 20 kilometers west of Broken Hill). Thackaringa is located approximately 1,000 kilometers and 500 kilometers from Sydney and Adelaide respectively and approximately 400 kilometers from the Spencer Gulf (Port Pirie). The portfolio consists of four mineral licenses: exploration license 6622 (1992) (EL 6622), exploration license 8143 (2013) (EL8143), mining lease 86 (1973) (ML 86) and mining lease 87 (1973) (ML 87).
  • Metals & Mining
~ $0.50
18

DENARIUS SILVER CORP. (XTSX:DSLV)

$0.49
DSLV
Denarius Silver Corp, formerly ESV Resources Ltd, is a Canada-based silver exploration company. The Company conducts its exploration activities of silver projects located in mining districts in Colombia. Its projects include Lomero-Poyatos Project, Guia Antigua Project and Zancudo Project. The Lomero-Poyatos Project is located in the north-east part of the Spanish/Portuguese Iberian Pyrite Belt in the Huelva Province of Southern Spain. The Guia Antigua Project is located in Segovia Mining District, Colombia. The Zancudo Project is located in the Titiribi mining district of Antioquia, approximately 27-kilometer (km) south of Medellin.
  • Metals & Mining
~ $0.50
9

ANDATEE CHINA MARINE FUEL SERVICES CORPORATION (OTCM:AMCF)

$0.11
AMCF
Andatee China Marine Fuel Services Corporation (Andatee) operates its business through its subsidiaries. The Company’s subsidiaries include Hong Kong subsidiary, Goodwill Rich, Fusheng, Fusheng’s variable interest entity (VIE) and Dalian Xingyuan. Through both directly controlled subsidiaries and VIE entities, the Company is engaged in the production, storage, distribution and wholesale purchases and sales of blended marine fuel oil for cargo and fishing vessels with operations in Liaoning, Shandong, Jiangsu and Zhejiang Provinces in People’s Republic of China (PRC). The Company’s products include cargo vessel fuel classified as CST180 and CST120, fishing boat fuel. The Company produces, stores, distributes and trades the blended marine fuel oil for cargo and fishing vessels.
  • Oil & Gas
~ $0.50
5

FORBES ENERGY SERVICES LTD. (OTCM:FLSS)

$0.06
FLSS
Forbes Energy Services Ltd. (FES Ltd.) is a holding company. The Company is an independent oilfield services contractor that provides a range of well site services to oil and natural gas drilling and producing companies to develop the production of oil and natural gas. The Company's segments are Well Servicing and Fluid Logistics. Its services include fluid disposal and well maintenance. The Company's Well Servicing segment provides an offering of well services to oil and natural gas companies, including completions of drilled oil and natural gas wells, wellbore maintenance, workovers and recompletions, tubing testing, and plugging and abandonment services. Its Fluid Logistics segment provides a range of oilfield fluid sales, transportation, storage and disposal services that are required on workover, drilling and completion projects, and are used in daily operation of producing wells by oil and natural gas producers. It operates approximately six coiled tubing spreads.
  • Oil & Gas Related Equipment and Services
~ $0.50
4

BG MEDICINE, INC. (OTCM:BGMD)

$0.04
BGMD
BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
  • Pharmaceuticals
~ $0.50
15

BODY AND MIND INC. (XCNQ:BAMM)

$0.44
BAMM
Body and Mind Inc. is a Canada-based company that invests in medical and recreational cannabis cultivation, manufacturing and retail. The Company’s wholly owned Nevada subsidiary holds medical marijuana cultivation and manufacturing licenses. The Company’s products include dried flower, edibles, oils and extracts, as well as GPEN Gio cartridges and Lucid Mood offerings. The Company operates in Nevada, California, Arkansas and Ohio.
  • Pharmaceuticals
~ $0.50
16

Core One Labs Inc. (XCNQ:COOL)

$0.45
COOL
Core One Labs Inc. (Core One) is a Canada-based biotechnology research and technology life sciences company. The Company is focused on advancing psychedelic medicines to market through delivery systems and psychedelic assisted psychotherapy. It has developed a patent pending thin film oral strip, which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining bioavailability. Core One also holds an interest in medical clinics, which maintain a combined database of approximately 275,000 patients.
  • Pharmaceuticals
~ $0.50
1

ASCENT SOLAR TECHNOLOGIES, INC. (OTCM:ASTI)

$0.02
ASTI
Ascent Solar Technologies, Inc. is engaged in commercializing flexible photovoltaic (PV) modules using its technology. The Company's manufacturing process deposits multiple layers of materials, including a thin film of copper-indium-gallium-diselenide (CIGS) semiconductor material, on a plastic substrate using a roll-to-roll manufacturing process and then laser patterns the layers to create interconnected PV cells or PV modules, in a process known as monolithic integration. The Company is producing consumer oriented products focusing on charging devices powered by its solar modules. It manufactures its products by affixing a thin CIGS layer to a flexible, plastic substrate using a roll-to-roll process. Its EnerPlex products are available in a range of third-party e-commerce sites, including www.amazon.com, www.brookstone.com, www.walmart.com, www.newegg.com and several others.
  • Renewable Energy
~ $0.50
22

ACORN ENERGY, INC. (OTCM:ACFN)

$0.60
ACFN
Acorn Energy, Inc. is a holding company. The Company is focused on technology driven solutions for energy infrastructure asset management. The Company operates through two segments: Power Generation (PG) monitoring and Cathodic Protection (CP) monitoring. The PG monitoring segment provides wireless remote monitoring and control systems and services for critical assets (including stand-by power generators, pumps, pumpjacks, light towers, turbines, compressors, as well as other industrial equipment), as well as Internet of Things applications. The CP monitoring segment provides for remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies. The Company's subsidiary includes OmniMetrixTM, LLC.
  • Software & IT Services
~ $0.50

Price Group
~ $1.00

34

BRDR Total Return Fundo de Investimento Multimerc

$1.08
36.484.248/0001-12
#FIELD!
  • #FIELD!
~ $1.00
44

ATON-Oblachnye tekhnol BPIFRFI (MISX:AMCC)

$1.37
AMCC
#FIELD!
  • #FIELD!
~ $1.00
50

FCS Viver FI Multimercado CP Investimento Exterior

$1.47
23.611.275/0001-67
#FIELD!
  • #FIELD!
~ $1.00
51

Epiq Multimercado Credito Privado FI

$1.62
34.771.866/0001-18
#FIELD!
  • #FIELD!
~ $1.00
37

ASTROTECH CORPORATION (XNAS:ASTC)

$1.15
ASTC
Astrotech Corporation is a science and technology development and commercialization company. The Company invents, acquires and commercializes technological innovations sourced from internal research, universities, laboratories and research institutions. The Company operates through two business units: Astro Scientific and Astral Images Corporation (Astral). The Astro Scientific is a technology incubator that commercializes technologies, and includes the operations of subsidiaries, such as 1st Detect Corporation (1st Detect) and Astrogenetix, Inc. (Astrogenetix). Astral segment provides film digitization, image correction and enhancement technology. It offers systems containing off-the-shelf hardware with integrated Astral software, software products and scanning or enhancement services. The Astral segment offers products, including Astral Black ICE, Astral Color ICE and Astral HDR ICE. The Company's product portfolio also consists of MMS-1000 and OEM-1000.
  • Aerospace & Defense
~ $1.00
29

AETERNA ZENTARIS INC. (XNAS:AEZS)

$0.84
AEZS
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.
  • Biotechnology & Medical Research
~ $1.00
30

CYTRX CORPORATION (OTCM:CYTR)

$0.88
CYTR
CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue sarcoma (STS) whose tumors have progressed after treatment with chemotherapy. It is also involved in evaluating aldoxorubicin in a Phase IIb clinical trial in small cell lung cancer; a Phase II clinical trial in human immunodeficiency virus-related Kaposi's sarcoma; a Phase II clinical trial in patients with late-stage glioblastoma (brain cancer); a Phase Ib trial in combination with ifosfamide in patients with STS, and a Phase Ib trial in combination with gemcitabine in subjects with metastatic solid tumors. It is engaged in the pre-clinical development for DK049, an anti-cancer drug conjugate that utilizes its Linker Activated Drug Release (LADR) technology.
  • Biotechnology & Medical Research
~ $1.00
38

CELSION CORPORATION (XNAS:CLSN)

$1.16
CLSN
Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
  • Biotechnology & Medical Research
~ $1.00
42

ACELRX PHARMACEUTICALS, INC. (XNAS:ACRX)

$1.23
ACRX
AcelRx Pharmaceuticals, Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidates include DSUVIA (known as DZUVEO in Europe) and Zalviso. Its DSUVIA is indicated for use in adults in a certified medically supervised healthcare setting, such as hospitals, surgical centers, and emergency departments, for the management of acute pain. DSUVIA is designed to provide rapid analgesia via a non-invasive route and to eliminate dosing errors associated with IV administration. Its Zalviso is a sufentanil sublingual tablet system intended for the management of moderate-to-severe acute pain in hospitalized adult patients. Zalviso consists of a pre-filled cartridge of 40 sufentanil sublingual tablets, 15 microgram (McG), delivered by the Zalviso System, a needle-free, handheld, patient-administered, pain management system.
  • Biotechnology & Medical Research
~ $1.00
43

AGILE THERAPEUTICS, INC. (XNAS:AGRX)

$1.30
AGRX
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.
  • Biotechnology & Medical Research
~ $1.00
46

CASI PHARMACEUTICALS, INC. (XNAS:CASI)

$1.39
CASI
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. It operates through the development of targeted therapeutics for the treatment of cancer segment. Its product pipeline includes internal development of its lead drug candidate, ENMD-2076; MARQIBO, ZEVALIN and EVOMELA, and early-stage candidates in preclinical development. Its ENMD-2076 is an orally active, Aurora A/angiogenic kinase inhibitor with a kinase selectivity profile and multiple mechanisms of action. Its Marqibo is a sphingomyelin/cholesterol liposome-encapsulated, formulation of vincristine sulfate. Its ZEVALIN (ibritumomab tiuxetan) injection for intravenous use is a CD20-directed radiotherapeutic antibody. Its EVOMELA is an intravenous formulation of melphalan being investigated by Spectrum in the multiple myeloma transplant setting. Its pipeline also includes 2ME2 (2-methoxyestradial).
  • Biotechnology & Medical Research
~ $1.00
47

ADMA BIOLOGICS, INC. (XNAS:ADMA)

$1.45
ADMA
ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.
  • Biotechnology & Medical Research
~ $1.00
48

DURECT CORPORATION (XNAS:DRRX)

$1.45
DRRX
Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY (oral controlled release oxycodone), ORADUR-ADHD, ELADUR (controlled release injection of bupivicane), Relday (risperidone), ORADUR-based opioid (hydromorphone) and SABER-based ophthalmic. The Company's ALZET product line consists of miniature, implantable osmotic pumps and accessories used for experimental research in mice, rats and other laboratory animals. The Company also manufactures and sells osmotic pumps used in laboratory research and design; and develops and manufactures a range of standard and custom biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products.
  • Biotechnology & Medical Research
~ $1.00
49

ATHERSYS, INC. (XNAS:ATHX)

$1.47
ATHX
Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
  • Biotechnology & Medical Research
~ $1.00
54

DIGITAL ALLY, INC. (XNAS:DGLY)

$1.69
DGLY
Digital Ally, Inc. produces digital video imaging and storage products for use in law enforcement, security and commercial applications. The Company's products include in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets; a system that provides its law enforcement customers with audio/video surveillance from multiple vantage points and hands-free automatic activation of body-worn cameras and in-car video systems; a weather-resistant mobile digital video recording system for use on motorcycles, all-terrain vehicles (ATVs) and boats; a miniature digital video system designed to be worn on an individual's body, and a hand-held laser speed detection device that it offers primarily to law enforcement agencies. The Company sells its products to law enforcement agencies and other security organizations, consumer and commercial fleet operators through direct sales domestically and third-party distributors internationally.
  • Communications & Networking
~ $1.00
31

CHINA JO-JO DRUGSTORES, INC. (XNAS:CJJD)

$0.91
CJJD
China Jo-Jo Drugstores Inc is a China-based company principally engaged in the retail and distribution of pharmaceutical and other healthcare products. The Company operates its business through four segments. The Retail Drugstores segment sells prescription and over-the-counter (OTC) drugs, nutritional supplements, traditional Chinese medicine (TCM), personal and family care products, medical devices, and convenience products, including consumable, seasonal, and promotional items. The Online Pharmacy segment sells certain OTC drugs, medical devices, nutritional supplements and other sundry products through third-party platforms such as Alibaba’s Tmall, JD.com and Amazon.com, and the Company’s own platform all over China. The Drug Wholesale segment supplies its own retail drugstores with prescription and OTC medicines, TCM, dietary supplement, medical devices and sundry items. The Herb Farming segment cultivates selected herbs for sales to other drug vendors.
  • Food & Drug Retailing
~ $1.00
39

DYNATRONICS CORPORATION (XNAS:DYNT)

$1.18
DYNT
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company's products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.
  • Healthcare Equipment & Supplies
~ $1.00
41

DYNASIL CORPORATION OF AMERICA (OTCM:DYSL)

$1.21
DYSL
Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology and optical components, as well as contract research. The Company operates through three segments, including Contract Research, Optics and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. (RMD) business unit. The Optics segment operates through four business units: Dynasil Fused Silica, Optometrics Corporation, Hilger Crystals, Ltd. and Evaporated Metal Films Corporation, which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a business unit, Dynasil Biomedical Corporation, a medical technology incubator, which owns rights to certain early-stage medical technologies.
  • Healthcare Equipment & Supplies
~ $1.00
45

ARC GROUP WORLDWIDE, INC. (OTCM:ARCW)

$1.39
ARCW
ARC Group Worldwide, Inc. is a manufacturing company. The Company has two segments: Precision Components Group, 3DMT Group. It provides a set of manufacturing solutions, from design and prototyping through production. Through the Company's product offering, it provides its customers with a prototyping and production solution for both precision metal and plastic fabrication. The Precision Components Group companies provide fabricated metal components using processes, consisting of metal injection molding, precision metal stamping and hermetic sealing. The 3DMT Group focuses on rapid prototyping, short-run production and rapid tooling.
  • Machinery
  • Equipment & Components
~ $1.00
40

CINEDIGM CORP. (XNAS:CIDM)

$1.21
CIDM
Cinedigm Corp. is a distributor and aggregator of independent movie, television and other short form content managing a library of distribution rights to thousands of titles and episodes released across digital, physical, and home and mobile entertainment platforms. The Company also provides digital cinema assets servicing on over 12,000 domestic and foreign movie screens. It operates through four segments: first digital cinema deployment (Phase I Deployment), the second digital cinema deployment (Phase II Deployment), digital cinema services and media content and entertainment group. It collaborates with producers, brands and other content owners to market, source, curate and distribute content to targeted audiences. It distributes content through existing and emerging digital home entertainment platforms and packaged distribution of DVD and Blu-ray discs to wholesalers and retailers and mortar storefronts. It also operates a branded and curated over-the-top entertainment channels.
  • Media & Publishing
~ $1.00
52

Aris Gold Corporation (OTCM:ALLXF)

$1.64
ALLXF
Aris Gold Corporation, formerly Caldas Gold Corp., is a Canada-based mining company. The Company is principally engaged in acquiring operating gold mines and projects. It is focused on operating the Marmato mine in Colombia, and the Juby project, which is an advanced exploration stage gold project in the Abitibi greenstone belt of Ontario, Canada. Marmato mine is located in the Marmato gold district in the Caldas Department, a mountainous region approximately 80 kilometers south of Medellin, Colombia. The Company's Juby project is located approximately 15 kilometers west-southwest of the town of Gowganda and around 100 kilometers south-southeast of the Timmins gold camp within the Shining Tree area in the southern part of the Abitibi greenstone belt. The Juby Project controls an area of approximately 14,000 acres through patented claims that covers around 10 kilometers strike length of the west-northwest trending Tyrrell Shear Zone (TSZ) in the Abitibi greenstone belt.
  • Metals & Mining
~ $1.00
33

ADAMIS PHARMACEUTICALS CORPORATION (XNAS:ADMP)

$1.03
ADMP
Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.
  • Pharmaceuticals
~ $1.00